Rapamune® (Sirolimus)

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Kidney Transplantation

Phase 2

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

CompletedNCT00518271

Wyeth is now a wholly owned subsidiary of PfizerKidney Transplantation

Start: 2000-04-30End: 2002-06-30Updated: 2007-08-20

Phase 4

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

CompletedNCT00518375

Wyeth is now a wholly owned subsidiary of PfizerKidney Transplantation

Start: 2000-04-30End: 2001-05-31Target: 250Updated: 2023-12-11

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

CompletedNCT00519116

Wyeth is now a wholly owned subsidiary of PfizerKidney Transplantation

Start: 2000-10-31End: 2001-08-31Target: 150Updated: 2023-12-11